Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-26T16:41:36.261Z Has data issue: false hasContentIssue false

EPA-0296 – Patient Management and Psychopharmacological Treatment Associated to Smoking Ban in an Acute Psychiatry Unit

Published online by Cambridge University Press:  15 April 2020

A. Toll Privat
Affiliation:
Psychiatry Resident, Institut de Neuropsiquiatria I Addiccions, Parc de Salut Mar
D. Bergé Baquero
Affiliation:
Psychiatrist, Institut de Neuropsiquiatria I Addiccions, Parc de Salut Mar
A. Mané Santacana
Affiliation:
Psychiatrist, Institut de Neuropsiquiatria I Addiccions, Parc de Salut Mar
J.M. Ginés Miranda
Affiliation:
Psychiatrist, Institut de Neuropsiquiatria I Addiccions, Parc de Salut Mar
V. Chavarria Romero
Affiliation:
Psychiatry Resident, Institut de Neuropsiquiatria I Addiccions, Parc de Salut Mar
B. Samsó Buxareu
Affiliation:
Psychiatrist, Institut de Neuropsiquiatria I Addiccions, Parc de Salut Mar
A. Merino Torres
Affiliation:
Psychiatrist, Institut de Neuropsiquiatria I Addiccions, Parc de Salut Mar
V. Pérez Solà
Affiliation:
Psychiatrist, Institut de Neuropsiquiatria I Addiccions, Parc de Salut Mar

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction:

More than 60% of psychiatric patients are smokers. Besides a culture of smoking allowance amongst these patients, in the last years all psychiatric services in developed countries are becoming smoking free. Several studies have found negative expectancies in staff and patients where smoking bans are planned. Nevertheless, not many studies have focused on objective measures as changes in medication and features of the admissions period.

Objectives:

We want to find differences in terms of clinical and treatment management in psychiatric hospitalization associated to smoking ban.

Methods:

We collected data (regarding medication, socio-demographic and admission characteristics) from all patients admitted to an acute psychiatric hospital in two different time periods, before and after the smoking ban was in force. We collected data (regarding medication, sociodemographic and admission characteristics) from all patients admitted to an acute psychiatric hospital in two different time periods, before and after the smoking ban was in force.

Results:

More number of leaves of absence (p=0,020) and movement restrictions (p=0,001) during the ban period occurred in comparison to the pre-ban period. On the contrary a lack of significant differences in terms of hospital stay (duration (p=0,479), rate of involuntary admissions (p=0,371) and voluntary discharges (p=0,377)), use of sedatives and doses of antipsychotics was found (p= 0,640 and p=0,194).

More number of leaves of absence (p=0,020) and movement restrictions (p=0,001) during the ban period occurred in comparison to the pre-ban period. On the contrary a lack of significant differences in terms of hospital stay (duration (p=0,479), rate of involuntary admissions (p=0,371) and voluntary discharges (p=0,377)), use of sedatives and doses of antipsychotics was found (p= 0,640 and p=0,194).

Conclusions:

The smoking-ban may have driven to increased grants for leave of absence that secondarily may have underpin demands for leave of absence in patients not allowed to and thus, it may have contribute to an increase in movement restrictions. Further studies with longer periods after the ban may clarify this issue. The smoking-ban may have driven to increased grants for leave of absence that secondarily may have underpin demands for leave of absence in patients not allowed to and thus, it may have contribute to an increase in movement restrictions. Further studies with longer periods after the ban may clarify this issue.

Type
EPW06 - Others 1
Copyright
Copyright © European Psychiatric Association 2014
Submit a response

Comments

No Comments have been published for this article.